Our results, regarding the association between anti-CCP2 and ILD, are similar to the findings by Nikiphorou et al. [10], who observed that anti-CCP2 titers are significantly higher in patients with RA who had ILD. The gene discussed is AGBL2; the disease is rheumatoid arthritis.